Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,095.00    -55.00 (-0.77%)
Bid:
7,065.00
Ask:
7,070.00
Spread: 5.00 (0.071%)
Market Cap: £9.51b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Q3 Trading Update

17 Jul 2025 07:00

RNS Number : 3603R
Diploma PLC
17 July 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

17 July 2025

 

STRONG Q3. FURTHER FY UPGRADE.

TWO ACQUISITIONS.

 

 

Diploma PLC issues a trading update for the nine months ended 30 June 2025.

 

· Strong Q3 performance. Full year upgrade to organic growth of 10% (from 8%).

Organic growth YTD of 10%: continuation of positive trends from H1.

Reported growth YTD of 12%: +4% from acquisitions, partly offset by FX.

Strong operating margin: in line with expectations (FY guidance c.22%).

 

· Invested c.£39m in two quality acquisitions:

Haagensen A/S (Seals), adding to M-Seals' capability in Denmark.

Alpha Laboratories (Life Sciences), marks our entry into the UK In Vitro Diagnostics market.

 

 

 

---------------------------------------------------------------------------------------------------

Johnny Thomson, Chief Executive Officer, and Chris Davies, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:00am (UK time).

 

Conference call dial in details:

• Dial in: +44 (0) 33 0551 0200

• Password: Diploma Q3

 

The next scheduled update is our full year results on 18 November 2025.

 

 

 

For further information please contact:

Diploma PLC -

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

 

Chris Davies, Chief Financial Officer

Holly Gillis, Head of Investor Relations

Teneo -

+44 (0)20 7353 4200

Martin Robinson

Camilla Cunningham

 

 

 

 

 

 

 

NOTE TO EDITORS:

 

Diploma's businesses deliver practical and innovative solutions that keep key industries moving. They have the technical expertise, specialist knowledge, and long-term relationships required to deliver value-add products and services that make our customers' lives easier and their outcomes better. These value-add solutions drive customer loyalty, market share growth and strong margins.

 

Our decentralised model means our specialist businesses are agile and empowered to deliver the right solutions for their customers, in their own way. As part of Diploma, our businesses can also leverage the additional resources, opportunities and expertise of a large, international and diversified Group to benefit their customers, colleagues, suppliers and communities.

 

We employ c.3,300 colleagues across our three Sectors of Controls, Seals and Life Sciences. Our principal operating businesses are located in North America, the UK, Europe, and Australia.

 

Diploma aims to deliver sustainable quality compounding, and over the last fifteen years, the Group has grown adjusted earnings per share (EPS) at an average of c.16% p.a. through a combination of organic growth and acquisitions.

Diploma is a member of the FTSE 100.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

The person responsible for releasing this Announcement is Anna Lawrence, Group Company Secretary.

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUBPMUPAGAQ
Date   Source Headline
14th Feb 202510:34 amRNSHolding(s) in Company
17th Jan 20259:34 amRNSDirector/PDMR Shareholding
15th Jan 20252:56 pmRNSResult of AGM
15th Jan 202510:19 amRNSAppointment of Non-Executive Director
15th Jan 20257:00 amRNS1st Quarter Results
10th Jan 20258:56 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20244:25 pmRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSBoard Committee Changes
27th Nov 20247:00 amRNSDirector/PDMR Grant of LTIP Awards
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
15th Nov 20247:00 amRNSIssue of Shares & Total Voting Rights
8th Oct 20247:00 amRNSAppointment of Non-Executive Director
13th Sep 20247:00 amRNSAppointment of Senior Independent Director
29th Jul 20242:25 pmRNSDirector Declaration
18th Jul 20247:00 amRNSQ3 Trading Statement
16th Jul 20247:00 amRNSBoard Changes
4th Jun 202411:18 amRNSHolding(s) in Company
13th May 20247:00 amRNSHalf Year Results
2nd May 20247:00 amRNSAcquisition
25th Apr 20243:54 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSAcquisition
5th Mar 20242:07 pmRNSHolding(s) in Company
17th Jan 20243:21 pmRNSResult of AGM
17th Jan 20247:00 amRNSQ1 trading update
20th Dec 20237:00 amRNSAppointment of Non-Executive Director
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202311:31 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSDirector/PDMR Grant of LTIP Awards
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSFull Year Results
16th Nov 20237:00 amRNSIssue of Shares & Total Voting Rights
10th Oct 202312:29 pmRNSHolding(s) in Company
21st Aug 202310:10 amRNSHolding(s) in Company
15th Aug 20233:54 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSStrategic acquisition in European Fluid Power
13th Jul 20237:00 amRNSQ3 Trading Update
27th Jun 20237:00 amRNSCapital Markets Seminar
13th Jun 20235:09 pmRNSHolding(s) in Company
7th Jun 20233:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.